Ceramic On Ceramic (COC) 36mm PAS IDE Rollover Subjects; Ceramic Acetabular Bearing With Ceramic Femoral Head in Total Hip Replacement



Status:Completed
Conditions:Arthritis, Osteoarthritis (OA), Orthopedic, Orthopedic
Therapuetic Areas:Rheumatology, Orthopedics / Podiatry
Healthy:No
Age Range:20 - 75
Updated:1/31/2019
Start Date:January 1, 2014
End Date:August 20, 2018

Use our guide to learn which trials are right for you!

36mm CERAMAX® Ceramic Hip System PMA PAS: Long-Term Follow-up of Previously Enrolled Investigational Device Exemption (IDE) Study Subjects

This study is intended to gather medium (5- to 7-years) and long-term (minimum 8- to
10-years) information regarding the performance and safety of the commercially available 36mm
CERAMAX® Ceramic on Ceramic (COC) Total Hip System from a cohort of study subjects that were
previously enrolled in the IDE study. (COC = 36mm ceramic acetabular bearing insert component
that articulates with a ceramic femoral head in the COC total hip replacement system)

Up to five (5) sites will participate. These sites participated in the IDE study and will
continue subject follow-up.

Subjects from the original IDE study (COC 36mm investigational subjects only) will be seen
for a clinic visit at the time of consent (First visit at approximately 5 to 7 years post-op
or 1825- 2919 days), and at minimum 8 years (2920-3649 days) , and minimum 10 years
(3650-4015 days). Harris Hip evaluation, radiographic evaluation, subject hip-outcomes, and
adverse event information will be collected at each visit.

If a subject is not willing or able to return for a clinical and radiographic follow-up for
either the minimum 8 year evaluation or the minimum 10 year evaluation, then a telephone
interview may be utilized for the purpose of determining device survivorship.

Inclusion Criteria:

- Subjects who were previously enrolled in the COC 36 IDE study;

- Individuals who are willing and able to provide informed patient consent for
participation in the study;

- Individuals who are willing and able to return for follow-up as specified by the study
protocol; and

- Individuals who are willing and able to complete the Subject Hip Outcomes
questionnaire as specified by the study protocol.

Exclusion Criteria:

- In the opinion of the Investigator, the individual does not qualify if there are any
concerns with the ability to follow the protocol specified evaluations.

- Any component of the primary total hip was previously revised.
We found this trial at
5
sites
?
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
?
mi
from
Alexandria, VA
Click here to add this to my saved trials
Columbus, Ohio 43213
?
mi
from
Columbus, OH
Click here to add this to my saved trials
?
mi
from
Denver, CO
Click here to add this to my saved trials
?
mi
from
Sacramento, CA
Click here to add this to my saved trials